Providers
DANIEL FERRIN LEAVITT, MD
NPI 1104160415, individual, Red Bluff, CA, Family Medicine
5
Evidence tier
informational
score 30 of 100, rank 11369, $299K at stake
National provider registry
From the CMS NPPES Registry, refreshed daily.
| Name | DANIEL FERRIN LEAVITT, MD |
| Type | Individual |
| Status | Active |
| NPI issued | November 27, 2012, last updated September 11, 2021 |
| Practice location | 2450 SISTER MARY COLUMBA DR, Red Bluff, CA 96080-4356, 530-527-0414 |
| Specialties | Family Medicine (207Q00000X, primary, license C172218 CA) |
Procedures billed
The specific codes behind the dollars. Medicaid figures come from T-MSIS (2018 to 2024) and are compared with every other provider billing the same code; Medicare figures come from the 2024 physician and supplier file and compare this provider's submitted charge with what Medicare allowed, against the usual ratio for that code.
Medicaid, largest codes
| code | what it is | paid | share | per patient-month | typical | rank among providers | |
|---|---|---|---|---|---|---|---|
| T1015 | Medicaid service code | $3.9M | 81% | $187 | $182 (top 5% from $488) | 52nd percentile | |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | $317K | 7% | $20 | $44 (top 5% from $110) | 16th percentile | |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | $139K | 3% | $26 | $60 (top 5% from $133) | 13th percentile | |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | $80K | 2% | $36 | $32 (top 5% from $49) | 65th percentile | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | $79K | 2% | $77 | $75 (top 5% from $185) | 54th percentile | |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | $52K | 1% | $49 | $67 (top 5% from $121) | 22nd percentile | |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | $52K | 1% | $50 | $44 (top 5% from $70) | 68th percentile | |
| 87634 | Detection test by nucleic acid for respiratory syncytial virus, amplified probe technique | $46K | 1% | $60 | $48 (top 5% from $77) | 69th percentile |
In this area
8 providers in Tehama County, CA carry an indicator in the public record, with $3.2M at stake between them. The most common is more hours than a day holds, on 5 of them, followed by part of a provider network on 2. 1 is tier 1: documented action, then payment.
| tier | provider | at stake | why |
|---|---|---|---|
| 1 | JAMES OOI Corning, CA, ranked 373 | $2K |
|
| 3 | RED BLUFF HEALTH CARE, INC. Red Bluff, CA, ranked 1905 | $0 |
|
| 3 | SHASTA VIEW CARE CENTER LLC Red Bluff, CA, ranked 2426 | $0 |
|
| 4 | KERRY WAITS Red Bluff, CA, ranked 7772 | $1.3M |
|
| 5 | JACOB STROMAN Red Bluff, CA, ranked 10171 | $747K |
|
| 5 | BRIAN LAIR Red Bluff, CA, ranked 10259 | $506K |
|
| 5 | LEE SHOOP Red Bluff, CA, ranked 10321 | $371K |
|
| 5 | JAMES MONTANA Red Bluff, CA, ranked 10356 | $261K |
|
Recent enforcement in CA
All releasesDepartment of Justice and HHS-OIG releases for this state, newest first. Each opens in a new tab.
DOJPleaded guiltyAug 27, 2026
Anaheim Woman Pleads Guilty to Submitting More Than $2.2 Million in Fraudulent Hospice Care Claims to Medicare
Galbraith submitted approximately $2,266,694 in claims to Medicare for hospice services for beneficiaries who did not have a terminal illness with a life expectancy of six months or less, and Medicare paid her company approximately $2,140,606.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. submitted claims to Medicare for skin cancer tests conducted with an unvalidated positive control range and for tests lacking sufficient patient RNA, and did not retract results or adequately refund Medicare.
DOJCivil settlementAug 26, 2026
DermTech Inc. to Pay Up to $5M to Resolve Allegations It Submitted False Claims to Medicare for Unreliable Skin Cancer Tests
DermTech Inc. billed Medicare for skin cancer tests conducted using an unvalidated positive control range and for tests with insufficient patient RNA, and did not retract the results or adequately refund Medicare.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4 Million to Settle False Claims Act Lawsuit
Monogram knowingly submitted diagnosis codes in four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to Medicare Advantage Organizations.
DOJCivil settlementAug 24, 2026
Medicare Advantage Provider Monogram Health Agrees to Pay $2.4M to Settle False Claims Act Suit
Monogram Health knowingly submitted diagnosis codes within four HCCs that were not clinically accurate, not supported by medical record documentation, and/or did not require or affect patient care, inflating Medicare Advantage beneficiaries' risk scores and causing CMS to make higher capitated payments to MAOs.
Referral packet
The packet is a draft for a reviewer. It reads every public record behind this case, states what the records show with a citation for each finding, names the regulation each finding relates to, and lists the ordinary explanations to rule out first. It never asserts intent.